NEU vs PHX

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

NEU

NEUREN FPO NZ [NEU]

47LOW

PHX

PHARMX FPO [PHX]

42LOW

Score Breakdown

NEU PHX
Technical
61
57
Catalyst
50
51
Sentiment
50
50
Fundamental
62
66
Momentum
26
55
Risk Gate
43
50

Key Metrics

NEU Metric PHX
$2.1BMarket Cap$79.1M
725KAvg Volume (20d)448K
+4.9%Short InterestN/A
$22.98552-Week High$0.200
$11.00052-Week Low$0.084
+0.2%Daily Change+0.0%
$16.530Reference Price$0.120
+8.7%ROE-5.9%
+47.1%Profit Margin-12.2%

Active Signals

NEU Signals

Beating the Small Ords index — relative strength of 1.37, so it's outpacing the pack
Trading above the 200-day average — the long-term trend is on your side
Cash positive / operating cashflow positive
Revenue in sharp decline (-81%)
Piotroski F-Score strong (7/9, low-confidence approx)
EPS estimates revised upward (+10pts)
Post-earnings drift: negative surprise (SUE -10)
Earnings in sharp decline (-88% QoQ)

PHX Signals

Beating the Small Ords index — relative strength of 1.12, so it's outpacing the pack
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Moderate P/S ratio (10.3x)
Small-cap ($20-100M)
Capital raise activity (1 events)
CANSLIM S: Tight float (41%)
Negative profit margins (-12%)

Ask Scout AI to compare NEU and PHX in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

NEU vs PYC →NEU vs TRI →NOX vs PAR →NOX vs SPL →NSB vs NTI →
NEU Full Analysis → PHX Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).